⏳ Fetching live dividend data...
Home › Calculator › IMCR Dividend Calculator 2026
Immunocore Holdings plc · NASDAQ
Price: $27.79 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IMCR → $10.99M in 10 years · $64.39/month
Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for patients with uveal melanoma that is either unresectable or has metastasized. Within oncology, Immunocore is progressing IMC-C103C through early-stage (Phase I/II) dose escalation trials for several solid tumor types, notably non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers. Another key oncology program, IMC-F106C, is also in Phase I/II dose escalation studies for a diverse array of solid malignancies, including NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. For infectious diseases, the company is advancing IMC-I109V in Phase I/II clinical trials for chronic hepatitis B virus, alongside IMC-M113V, which is undergoing preclinical development for human immunodeficiency virus (HIV). Additionally, Immunocore is developing novel therapeutic candidates designed to deliver precise, targeted immunosuppression as a treatment strategy for autoimmune conditions.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IMCR position with:
Real after-tax yield depends on where you live and how you hold IMCR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 7.20% | 4.40% | $720 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 6.12% | 3.32% | $612 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 5.76% | 2.96% | $576 / yr |
| 🇬🇧 UK ISA | 0% | 7.20% | 4.40% | $720 / yr |
| 🇬🇧 UK Taxable | 8.75% | 6.57% | 3.77% | $657 / yr |
| 🇨🇦 TFSA | 0% | 7.20% | 4.40% | $720 / yr |
| 🇨🇦 CA Taxable | 25% | 5.40% | 2.60% | $540 / yr |
| 🇦🇺 Super (pension) | 15% | 6.12% | 3.32% | $612 / yr |
| 🇦🇺 AU Taxable | 30% | 5.04% | 2.24% | $504 / yr |
| 🇩🇪 DE Taxable | 26.375% | 5.30% | 2.50% | $530 / yr |
| 🇫🇷 FR Taxable | 30% | 5.04% | 2.24% | $504 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IMCR pays quarterly — 4 times per year. Next ex-div: TBD.
How IMCR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IMCR sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-05-27 | 27,492 | $28.52 | $784.1K | ||
| A-Award | 2026-05-27 | 27,492 | $28.52 | $784.1K | ||
| A-Award | 2026-05-27 | 27,492 | $28.52 | $784.1K | ||
| A-Award | 2026-05-27 | 27,492 | $28.52 | $784.1K | ||
| A-Award | 2026-05-27 | 27,492 | $28.52 | $784.1K | ||
| A-Award | 2026-05-27 | 27,492 | $28.52 | $784.1K | ||
| A-Award | 2026-02-17 | 95,637 | $32.38 | $3.10M | ||
| A-Award | 2026-02-17 | 33,353 | — | — | ||
| A-Award | 2026-02-17 | 395,066 | $32.38 | $12.79M | ||
| A-Award | 2026-02-17 | 88,573 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IMCR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →